Security key
037326105
AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX)
CUSIP: 037326105
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / Common Stock, par value $0.00001 per share
- Total 13F shares
- 9,212,310
- Total 13F value
- $49,010,711
- Share change
- -54,380
- SEC-reported price per share
- $5.32
- Number of holders
- 35
- Value change
- -$208,950
- Number of buys
- 19
- Number of sells
- 8
- Shares outstanding
- 38,076,587
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
35
Top holders
10
ANTX full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q2 2026
AN2 Therapeutics, Inc. SEC filings
AN2 Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 037326105
Recent filing periods:
Ownership snapshot
Top reported holders of ANTX - AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Coastlands Capital LP
Disclosed value leader
Adjuvant Global Health Te...
Comparable rows
10/15
Latest evidence
30 Sep 2026
13D/G
13F
3/4/5
Lead comparable stake: 10%
5 rows are not safely comparable across share classes.
13D/G row: Coastlands Capital LP
Showing 1-6 of 15 holder rows.
Quick read
Coastlands Capital LP leads the comparable SEC ownership view at 10%.
10 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Coastlands Capital LP's linked filing trail.
Comparable ownership
Top 5
Coastlands Capital LP
10%
Commodore Capital LP
9.9%
Coastlands Capital Partners LP
9.3%
Vivo Opportunity Fund Holdings, L.P.
8%
Adjuvant Global Health Technology...
7.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Coastlands Capital LP |
13D/G
|
10%
Reported 13D/G
· 30 Sep 2026
|
$20,236,487
3,803,851 shares
|
$0 | 30 Sep 2026 |
| Commodore Capital LP |
13F
13D/G
Company
|
9.9%
Reported 13D/G
· 09 Mar 2026
|
$14,199,011
2,933,680 shares
|
— | 30 Jun 2026 |
| Coastlands Capital Partners LP |
13D/G
Coastlands Capital LP
|
9.3%
Reported 13D/G
· 28 May 2025
|
$3,632,511
2,815,900 shares
|
$0 | 28 May 2025 |
| Vivo Opportunity Fund Holdings, L.P. |
13D/G
|
8%
Reported 13D/G
· 10 Mar 2026
|
$3,780,937
2,864,346 shares
|
$0 | 10 Mar 2026 |
| Adjuvant Global Health Technology Fund, L.P. |
3/4/5
13D/G
10%+ Owner · Adjuvant Capital GP, L.P.
|
7.9%
Reported 13D/G
· 31 Dec 2024
|
$45,367,317
2,373,500 shares
|
— | 16 Jan 2024 |
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
Millennium Management LLC
|
6.3%
Reported 13D/G
· 06 Mar 2026
|
$2,952,975
2,237,102 shares
|
$0 | 06 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
35
Shares
9,212,310
Rows available
35
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
66
Q3 2026 holders
35
Holder diff
-31
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend